These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22356797)

  • 1. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy.
    Sorajja P; Allison T; Hayes C; Nishimura RA; Lam CS; Ommen SR
    Am J Cardiol; 2012 May; 109(10):1494-8. PubMed ID: 22356797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac output response and peripheral oxygen extraction during exercise among symptomatic hypertrophic cardiomyopathy patients with and without left ventricular outflow tract obstruction.
    Critoph CH; Patel V; Mist B; Elliott PM
    Heart; 2014 Apr; 100(8):639-46. PubMed ID: 24449719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for routine use of metabolic stress testing in hypertrophic cardiomyopathy.
    Jacoby D; McKenna WJ
    Am J Cardiol; 2012 May; 109(10):1534-5. PubMed ID: 22546210
    [No Abstract]   [Full Text] [Related]  

  • 6. Rest and latent obstruction in hypertrophic cardiomyopathy: impact on exercise tolerance.
    Re F; Zachara E; Avella A; Baratta P; Di Mauro M; Penco M; Musumeci F; Tondo C
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):372-9. PubMed ID: 22728835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.
    Dumont CA; Monserrat L; Peteiro J; Soler R; Rodriguez E; Bouzas A; Fernández X; Pérez R; Bouzas B; Castro-Beiras A
    Am J Cardiol; 2007 May; 99(10):1454-7. PubMed ID: 17493479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure.
    Lang CC; Karlin P; Haythe J; Tsao L; Mancini DM
    Am J Cardiol; 2007 Feb; 99(3):404-5. PubMed ID: 17261407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
    G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of treadmill exercise echocardiography in the evaluation of symptomatic hypertrophic cardiomyopathy with latent obstruction. Impact on therapeutic decisions.
    Almeida AR; Cotrim C; Alves LB; Almeida S; Miranda R; Stuart B; Carrageta M
    Rev Port Cardiol; 2010 Dec; 29(12):1867-71. PubMed ID: 21428141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
    Coats CJ; Rantell K; Bartnik A; Patel A; Mist B; McKenna WJ; Elliott PM
    Circ Heart Fail; 2015 Nov; 8(6):1022-31. PubMed ID: 26374874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
    Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy.
    Schaff HV; Brown ML; Dearani JA; Abel MD; Ommen SR; Sorajja P; Tajik AJ; Nishimura RA
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):634-40. PubMed ID: 20176208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy with longevity to 90 years or older.
    Maron BJ; Casey SA; Haas TS; Kitner CL; Garberich RF; Lesser JR
    Am J Cardiol; 2012 May; 109(9):1341-7. PubMed ID: 22381158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standing position alone or in combination with exercise as a stress test to provoke left ventricular outflow tract gradient in hypertrophic cardiomyopathy and other conditions.
    Dimitrow PP; Cheng TO
    Int J Cardiol; 2010 Sep; 143(3):219-22. PubMed ID: 20442001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.